🇺🇸 FDA
Patent

US 11207322

Method and composition related to combination therapy for addiction

granted A61KA61K31/506A61K31/55

Quick answer

US patent 11207322 (Method and composition related to combination therapy for addiction) held by The Board of Regents of the University of Texas System expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/506, A61K31/55, A61K45/06, A61P